Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma
Open Access
- 10 June 2013
- journal article
- Published by Springer Nature in BMC Medical Imaging
- Vol. 13 (1) , 17
Abstract
A major challenge in the development of cell based therapies for glioma is to deliver optimal number of cells (therapeutic dose) to the tumor. Imaging tools such as magnetic resonance imaging (MRI), optical imaging, positron emission tomography (PET) and single-photon emission computed tomography (SPECT) has been used in cell tracking and/or biodistribution studies. In this study, we evaluate the dynamic biodistribution of systemic injected labeled cells [human cord blood derived endothelial progenitor cells (EPCs) and cytotoxic T-cells (CTLs)] in rat glioma model with in vivo SPECT imaging.Keywords
This publication has 26 references indexed in Scilit:
- Stem cell-based therapy for malignant gliomaCancer Treatment Reviews, 2013
- Stem cells based therapy in high grade glioma: why the intraventricular route should be preferred?2012
- Stem cell based glioblastoma gene therapyNeoplasma, 2012
- Differentiation of Glioma and Radiation Injury in Rats Using In Vitro Produce Magnetically Labeled Cytotoxic T-Cells and MRIPLOS ONE, 2010
- Optimization and Validation of FePro Cell Labeling MethodPLOS ONE, 2009
- Detection of migration of locally implanted AC133 + stem cells by cellular magnetic resonance imaging with histological findingsThe FASEB Journal, 2008
- Cellular MRI and its Role in Stem Cell TherapyRegenerative Medicine, 2008
- Magnetic Resonance Imaging and Confocal Microscopy Studies of Magnetically Labeled Endothelial Progenitor Cells Trafficking to Sites of Tumor AngiogenesisStem Cells, 2005
- Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients.1998
- Long-Term Survival in Patients with Malignant AstrocytomaNeurosurgery, 1994